Skip to main content
SpringerLink
Log in

Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The aim of the present study is to clarify the roles of circulating ADAMTS13 and von Willebrand factor (VWF) in the formation of coronary artery thrombi in acute myocardial infarction (AMI). Twenty-six AMI patients, 37 age-matched healthy controls, and 20 young controls were studied. Plasma ADAMTS13 activity and levels of VWF antigen (VWF: Ag) and unusually large VWF multimer (UL-VWFM) were measured in the femoral vein (FV), aortic root (Ao), and coronary sinus (Cs) immediately before percutaneous coronary intervention (PCI) during the acute phase of AMI, as well as 6 months later. During the acute phase of AMI, plasma levels of VWF: Ag were similar in FV, Ao, and Cs, and were higher than those of age-matched control. In contrast, ADAMTS13 activity in three sampling points in AMI patients was similar to that of age-matched controls. Thus, the ratio of VWF: Ag to ADAMTS13 activity in the acute phase of AMI was significantly higher in all three sampled sites than that of age-matched controls. In the chronic phase, plasma levels of VWF: Ag, ADAMTS13 activity, and the ratio of VWF: Ag to ADAMTS13 activity were similar to those of age-matched controls. UL-VWFM was detected in the acute phase of AMI but not in the chronic phase. The present study showed that the plasma VWF: Ag levels are increased and ADAMTS13 activity is relatively decreased in both systemic and coronary circulation during the acute phase of AMI, suggesting that an imbalance between the enzyme and its substrate may play a role in the formation of occlusive thrombi in a coronary artery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoshiba Y, Hatakeyama K, Tanabe T, Goto S (2006) Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 4:114–120

    Article  PubMed  CAS  Google Scholar 

  2. Mandelkorn JB, Wolf NM, Singh S, Shechter JA, Kersh RI, Rodgers DM, Workman MB, Bentivoglio LG, LaPorte SM, Meister SG (1983) Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol 52:1–6

    Article  PubMed  CAS  Google Scholar 

  3. Murasaki K, Kawana M, Murasaki S, Tsurumi Y, Tanoue K, Hagiwara N, Kasanuki H (2007) High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery disease. Heart Vessels 22:229–236

    Article  PubMed  Google Scholar 

  4. Ruggeri ZM (1997) von Willebrand factor. J Clin Invest 100: S41–S46

    PubMed  CAS  Google Scholar 

  5. Eto K, Isshiki T, Yamamoto H, Takeshita S, Ochiai M, Yokoyama N, Yoshimoto R, Ikeda Y, Sato T (1999) AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndrome. Arterioscler Thromb Vasc Biol 19:877–882

    PubMed  CAS  Google Scholar 

  6. Sakai H, Goto S, Kim JY, Aoki N, Abe S, Ichikawa N, Yoshida M, Nagaoka Y, Handa S (2000) Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 84:204–209

    PubMed  CAS  Google Scholar 

  7. Jansson JH, Nilsson TK, Johnson O (1991) von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 66:351–355

    Article  PubMed  CAS  Google Scholar 

  8. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease. Circulation 96:1102–1108

    PubMed  CAS  Google Scholar 

  9. Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K (2002) von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol 75:25–34

    Article  PubMed  CAS  Google Scholar 

  10. Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y (2006) Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 46:1444–1452

    Article  PubMed  CAS  Google Scholar 

  11. Matsumoto M, Kawaguchi S, Ishizashi H, Yagi H, Iida J, Sakaki T, Fujimura Y (2005) Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb 34:35–40

    Article  PubMed  CAS  Google Scholar 

  12. Goto S, Sakai H, Goto M, Ono M, Ikeda Y, Handa S, Ruggeri ZM (1999) Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 99:608–613

    PubMed  CAS  Google Scholar 

  13. Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H (2006) Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost 4: 2490–2493

    Article  PubMed  CAS  Google Scholar 

  14. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108:1772–1778

    Article  PubMed  Google Scholar 

  15. Goto S (2004) Propagation of arterial thrombi: local and remote contributory factors. Arterioscler Thromb Vasc Biol 24:2207–2208

    Article  PubMed  CAS  Google Scholar 

  16. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T (1985) Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313:1315–1322

    PubMed  CAS  Google Scholar 

  17. Claus RA, Bockmeyer CL, Sossdorf M, Losche W, Hilberg T (2006) Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation. J Thromb Haemost 4:902–905

    Article  PubMed  CAS  Google Scholar 

  18. Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto T, Mori T, Wanaka A, Fukui H, Fujimura Y (2005) Localization of ADAMTS13 to the stellate cells of human liver. Blood 106:922–924

    Article  PubMed  CAS  Google Scholar 

  19. Turner N, Nolasco L, Tao Z, Dong JF, Moake J (2006) Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 4:1396–1404

    Article  PubMed  CAS  Google Scholar 

  20. Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, Ashida S, Soejima K, Okada Y, Ikeda Y (2004) Detection of von Willebrand factor-cleaving protease (ADAMTS13) in human platelets. Biochem Biophys Res Commun 313:212–216

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, 634-8521, Japan

    Manabu Horii, Shiro Uemura, Keiichi Imagawa, Hajime Iwama, Yukiji Takeda, Hiroyuki Kawata, Tamio Nakajima & Yoshihiko Saito

  2. Third Department of Internal Medicine, Nara Medical University, Kashihara, Japan

    Masahito Uemura

  3. Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan

    Masanori Matsumoto, Hiromichi Ishizashi & Yoshihiro Fujimura

Authors
  1. Manabu Horii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiro Uemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahito Uemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanori Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiromichi Ishizashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiichi Imagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hajime Iwama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yukiji Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroyuki Kawata
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tamio Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoshihiro Fujimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yoshihiko Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihiko Saito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horii, M., Uemura, S., Uemura, M. et al. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23, 301–307 (2008). https://doi.org/10.1007/s00380-008-1053-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1053-x

Key words

Search

Navigation